Accelerating the commercialisation of a disruptive analytical technology which enables the biopharmaceutical industry to manufacture drugs faster, cheaper and with greater regulatory confidence

Livrables

Ensuring that Valitacell product and associated has the required CE registration

Submission of results and outline of applicability and benefits of technology in a report to be published in a peer reviewed journal or online publication

Results exchanged

Review of the results from the four sites and analysis of same in order to determine the final model to be adopted in the product

Publications

High-throughput quantitation of Fc-containing recombinant proteins in cell culture supernatant by fluorescence polarization spectroscopy

Auteurs: Ben Thompson, Jerry Clifford, Mike Jenns, Andrew Smith, Ray Field, Kalpana Nayyar, David C. James
Publié dans: Analytical Biochemistry, Numéro 534, 2017, Page(s) 49-55, ISSN 0003-2697
Éditeur: Academic Press
DOI: 10.1016/j.ab.2017.07.013

Droits de propriété intellectuelle

A METHOD OF MEASURING ANTIBODY CONCENTRATION IN A SAMPLE

Numéro de demande/publication: EP 15736411
Date: 2015-06-18
Demandeur(s): VALITACELL LTD

A METHOD OF PREDICTING PHENOTYPIC INSTABILITY IN A CELL

Numéro de demande/publication: EP 15718799
Date: 2015-04-02
Demandeur(s): VALITACELL LTD

A METHOD OF MEASURING ANTIBODY CONCENTRATION IN A SAMPLE

Numéro de demande/publication: EP 15736411
Date: 2015-06-18
Demandeur(s): VALITACELL LTD

A METHOD OF PREDICTING PHENOTYPIC INSTABILITY IN A CELL

Numéro de demande/publication: EP 15718799
Date: 2015-04-02
Demandeur(s): VALITACELL LTD

chemstress

Numéro de demande/publication: TM 017262511
Date: 2018-02-12
Demandeur(s): VALITACELL LTD

chemstress

Numéro de demande/publication: TM 017262511
Date: 2018-02-12
Demandeur(s): VALITACELL LTD

A METHOD OF PREDICTING RELATIVE FED BATCH PRODUCTION TITER OF A PANEL OF CLONALLY-DERIVED PRODUCER CELLS

Numéro de demande/publication: EP 14830805
Date: 2014-12-17
Demandeur(s): VALITACELL LTD